A carregar...

Biomarkers and surrogate endpoints in kidney disease

Kidney disease and its related comorbidities impose a large public health burden. Despite this, the number of clinical trials in nephrology lags behind many other fields. An important factor contributing to the relatively slow pace of nephrology trials is that existing clinical endpoints have signif...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Nephrol
Autor principal: Hartung, Erum A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4646734/
https://ncbi.nlm.nih.gov/pubmed/25980469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3104-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!